Individualized Drug Treatment for Treating Patients With Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Gemcitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Celecoxib or Observation After Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Phase II Trial Comparing ABI-007 (Abraxane®, Nab®-Paclitaxel) to Taxotere in First Line Therapy of Patients With Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])
- Status
- TERMINATED
- Phase
- PHASE3
Avastin/Docetaxel/Carboplatin in Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel in Hormone Refractory Prostate Cancer (HRPC)[Weekly or 3weekly TAX + Prednisone in HRPC]
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel in Squamous Cell Carcinoma of the Head and Neck (TAX + Cisplatin in SCCHN)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx
- Status
- TERMINATED
- Phase
- PHASE3
Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Docetaxel in Non Small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy.
- Status
- TERMINATED
- Phase
- PHASE2
Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE2
OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2